Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Guinea Pig |
| Stage: | Assays Completed |
| Study Start Date: | 2011-11-03 |
| Study Made Public: | 2012-08-09 |
Title
Prime boost immunization study with Subtype A/G recombinant Env gp140 and V3 peptide
Description
CAVD 273 is a guinea pig study assessing immune focusing response with gp140-CA018 and V3 were immunized in guinea pigs alone or in prime boost combination with different adjuvants.
Sign in to see full information about this study and to download study data.
Products
MF59 Carbopol 971 Env gp140 CA018 V3 mimeticIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.